IMAC Holdings Prices $2.65 Million Common Stock Offering
June 18, 2020 08:45 ET
|
IMAC Holdings, Inc.
BRENTWOOD, Tenn., June 18, 2020 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC), a provider of innovative medical advancements and care specializing in regenerative rehabilitation orthopedic...
IMAC Initiates Sale of BioFirma Subsidiary
November 12, 2019 08:00 ET
|
IMAC Holdings, Inc.
IMAC Will Retain Long-Term Supply Agreement at Discount BRENTWOOD, Tenn., Nov. 12, 2019 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (the “Company” or “IMAC”), a provider of innovative...
IMAC HOLDINGS ANNOUNCES FAVORABLE NEW LONG-TERM OUTCOMES DATA FROM REGENERATIVE REHABILITATION FOR MUSCULOSKELETAL CONDITIONS
May 28, 2019 09:00 ET
|
IMAC Holdings, Inc.
At an Average of 17 Months Post-Treatment, Quality-of-Life Score Improved 50% and Pain was Reduced 46% Without the Use of Opioids BRENTWOOD, Tenn, May 28, 2019 (GLOBE NEWSWIRE) -- IMAC Holdings,...
IMAC Holdings, Inc. Announces Research Scientist, Dr. Ian White, Joins IMAC Regeneration Centers As Chief Scientific Officer
September 13, 2018 15:16 ET
|
IMAC Holdings, Inc.
Brentwood, TN, Sept. 13, 2018 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (“IMAC”), a provider of regenerative rehabilitation orthopedic medical treatments without the use of surgery or opioids,...